In some countries, GLP-1 has been applied to the long-term treatment of clinical obesity, and GLP-1 can promote nerve growth and reduce neuroinflammation, which has become a hotspot in the research of neurodegenerative therapy (21). This evidence concerns the gene GCG and obesity disorder.